DNA X, Inc. Net Income Loss

• DNA X, Inc. showed a decrease of -37,286.7% in Net Income Loss from 2023 to 2024.
• This data is from DNA X, Inc.'s annual report (Form 10-K), filed with the SEC on March 31, 2025.
• XBRL data for this metric is available from 2018 to 2024 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 7 years of available data (2018 to 2024), DNA X, Inc.'s Net Income Loss has declined by 2,734.9%.
• Historical annual values: Fiscal year 2024: -$33.65 million | Fiscal year 2023: -$90.0 thousand | Fiscal year 2022: -$14.09 million | Fiscal year 2021: -$38.63 million | Fiscal year 2020: -$29.93 million | Fiscal year 2019: -$25.83 million | Fiscal year 2018: $1.28 million.
• Data sourced from SEC EDGAR public filings as of June 20, 2026.

Last verified: June 20, 2026